Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2003

View Archived Issues

Sodium oxybate improves pain, fatigue and sleep patterns in fibromyalgia patients

PDE inhibitor counteracts sexual dysfunction associated with fluoxetine use

Use of oxymetholone to counter HIV wasting

VIP as a potential treatment for patients with primary pulmonary hypertension

First human data and further preclinical findings discussed for CAB-175

Solifenacin succinate safe and effective in patients with overactive bladder

Four series of inhibitors of IGF-1R, IR and IRR identified at Merck

Novel alpha7 nAChR agonists and their use described by P&U (Pfizer)

Pfizer presents new PDE9 inhibitors with utility in hypertension therapy

Novel series of NR2B-selective NMDA antagonists covered by Roche patent

Roche claims new retinoid agonists with utility in emphysema, cancer and dermatological disorders

Tau protein kinase inhibitors designed by Mitsubishi and Sanofi-Synthelabo scientists

Novel series of HIV integrase inhibitors presented by Italian researchers

Higher GI-related expenses for Fosamax patients versus Actonel patients

INS-37217 Intranasal fails to meet primary endpoint in perennial allergic rhinitis trial

Phase I trial of interferon enhancer EMZ-701 completed

CPMP contraindicates concomitant use of repaglinide and gemfibrozil

Advanced Life Sciences licenses ALS-499 from Argonne National Laboratory

Novartis Generics rebranded as Sandoz

Valentis licenses delivery technology to Juvaris

Patient enrollment begins in phase II trial of ThGRF in HIV-related lipodystrophy

Speedel acquires full rights to SPP-301 from Roche

EMEA hands down positive opinion on Humira

Ipsen acquires development rights to SJG-136 from Spirogen

Biovitrum and GSK to focus efforts on highly selective 5-HT2C receptor agonists

CeNeS divests three products, allocates profits

Wyeth and Takeda sign new partnership agreements

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....